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ABSTRACT
Understanding data on novel coronavirus (COVID-19) pandemic, and modeling such data
over time are crucial for decision making at managing, fighting, and controlling the spread of this
emerging disease. This thesis work looks at some aspects of exploratory analysis and modeling
of COVID-19 data obtained from the Florida Department of Health (FDOH). In particular, the
present work is devoted to data collection, preparation, description, and modeling of COVID-19
cases and deaths reported by FDOH between March 12, 2020, and April 30, 2021.
For modeling data on both cases and deaths, this thesis utilized an autoregressive
integrated moving average (ARIMA) times series model. The “IDENTIFY” statement of SAS
PROC ARIMA suggests a few competing models with suggested values of the parameter p (the
order of the Autoregressive model), d (the order of the differencing), and q (the order of the
Moving Average model). All suggested models are then compared using AIC (Akaike Information
Criterion), SBC (Schwarz Bayes Criterion), and MAE (Mean Absolute Error) values, and the bestfitting models are then chosen with smaller values of the above model comparison criteria. To
evaluate the performance of the model selected under this modeling approach, the procedure is
repeated using the first six month’s data and forecasting the next 7 days data, nine month’s data
and forecasting the next 7 days data, and then all reported FDOH data from March 12, 2020, to
April 30, 2021, and forecasting the future data.
The findings of exploratory data analysis that suggests higher COVID-19 cases for females
compared to males and higher male deaths compared to females are taken into consideration by
evaluating the performance of final models by gender for both cases and deaths’ data reported by
FDOH. The gender-specific models appear to be better under model comparison criteria Mean
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Absolute Error (MAE) and Root Mean Squared Error (RMSE) compared to models based on
gender aggregated data.
It is observed that the fitted models reasonably predicted the future numbers of confirmed
cases and deaths. Given similarities in reported COVID-19 data, the proposed modeling approach
can be applied to data in the USA and many other States, and countries around the world.

iv

To My Parents, Brother, and Husband

v

ACKNOWLEDGMENTS
At first, I would like to express my gratitude and thanks to my supervisor Dr. Nizam
Uddin. I am truly grateful to him, not only as a supervisor but also as a mentor. His constant
guidance, valuable suggestions, encouragement, and innovative ideas were the driving force
behind this research work. He has taught me the art of quality research and independent thinking.
I am thankful to him for everything he has done for me and for helping me to do this work.
I would like to express my special gratitude to Dr. Alexander Mantzaris, and Dr. Mitch
Hill for their time and suggestions, and for being a member of my thesis committee.
I would like to pay my thanks to Dr. Edgard Maboudou for his help and support to take
the thesis.
Finally, I would like to express my gratitude to my husband for his help, support, and
encouragement in every aspect of my life; and to my parents and brother, who raised me and
trusted me with their endless love.

vi

TABLE OF CONTENTS

LIST OF FIGURES .................................................................................................................. ix
LIST OF TABLES ................................................................................................................... xii
CHAPTER 1: BACKGROUND ..................................................................................................1
1.1 Introduction ...........................................................................................................1
1.2 COVID-19 and Current world ................................................................................4
1.3 Motivation and Objectives .....................................................................................5
1.4 References .............................................................................................................6
CHAPTER 2: LITERATURE REVIEW .....................................................................................9
2.1 Literature review ....................................................................................................9
2.2 References ........................................................................................................... 15
CHAPTER 3: DATA COLLECTION AND PREPARATION .................................................. 17
3.1 Data Collection .................................................................................................... 17
3.2 Data preparation................................................................................................... 18
3.3 References ........................................................................................................... 24
CHAPTER 4: DATA DESCRIPTION ...................................................................................... 25
4.1 Descriptive Analysis ............................................................................................ 25
4. 2 References .......................................................................................................... 34
CHAPTER 5: METHODS AND MODEL................................................................................. 35

vii

5. 1 Time series ARIMA model ................................................................................. 35
5. 2 Strategy for developing the ARIMA model of COVID-19 data in Florida ........... 37
5. 3 Model Identification for log_Deaths variable ...................................................... 42
5.4 Estimation and diagnostic checking for log_Deaths variable ................................ 47
5.5 Forecasting for COVID-19 log_Deaths ................................................................ 49
5.5.1 First Six Months ............................................................................................ 49
5.5.2. FIRST Nine months: .................................................................................... 53
5.5.3 Thirteen months: ........................................................................................... 56
5.6 Forecasting for COVID-19 log_Cases .................................................................. 63
5.6.1 Model Identification for log_Cases variables ................................................. 64
5.6.2 Estimation and diagnostic checking for log_Cases variable ........................... 68
5.6.3 Forecasting for Six months ............................................................................ 69
5.6.4 Forecasting for Nine months ......................................................................... 72
5.6.5 Forecasting for Thirteen months .................................................................... 76
5.7 References ........................................................................................................... 84
CHAPTER 6: CONCLUSION .................................................................................................. 85

viii

LIST OF FIGURES
Figure 1: State-mandated stay-at-home orders by date implementation [7]. .................................2
Figure 2 : (a) Distribution of cases of COVID-19 pandemic and (b) Distribution of COVID-19
deaths worldwide, by continent [11]. ...........................................................................................5
Figure 3: Florida’s COVID-19 daily cases and deaths from March 24 to April 30, 2021 [6]. .... 10
Figure 4: Daily COVID-19 cases from March 12, 2020, to April 30, 2021, in Florida ............... 25
Figure 5: Daily COVID-19 deaths from March 2020 to April 2021 in Florida ........................... 26
Figure 6: Daily COVID-19 cases of male and female in Florida ................................................ 28
Figure 7: Daily COVID-19 deaths of male and female in Florida .............................................. 30
Figure 8: COVID-19 cases for male and female based on different Age_group ......................... 32
Figure 9: COVID-19 deaths for male and female based on different Age_group........................ 33
Figure 10: (a) The rolling mean and standard deviation of the number of COVID-19 cases and(b)
The rolling mean and standard deviation of the number of COVID-19 deaths ........................... 38
Figure 11: (a) the rolling mean and standard deviation for the logarithm of COVID-19 cases, and
(b) the rolling mean and standard deviation for the logarithm of COVID-19 deaths. .................. 40
Figure 12: (a) the rolling mean and standard deviation for the COVID-19 log_Cases, and (b) the
rolling mean and standard deviation for the COVID-19 log_Deaths after differencing the data (
the period of difference = 1) ...................................................................................................... 40
Figure 13: Log_Deaths is shown as a function of the Date......................................................... 42
Figure 14: Autocorrelation Analysis Plots for stationary series of the log_Deaths...................... 45
Figure 15: Forecast of log_Deaths for the ARIMA model (p = 0, d = 1, q = (1, 6, 7)) for next 7
days first six month’s data with 95% confidence limits.............................................................. 50

ix

Figure 16: Daily covid-19 actual log_Deaths and predicted log_Deaths for the first six months and
forecasted log_Deaths for the next seven days in Florida. .......................................................... 51
Figure 17: Comparing daily COVID-19 actual deaths and predicted deaths for the first six months
and forecasted deaths for the next seven days. ........................................................................... 52
Figure 18: Forecast of log_deaths for the ARIMA model (p = 0, d = 1, q = (1, 6, 7)) for the next 7
days of the first nine months’ data with 95% confidence limits. ................................................. 54
Figure 19: Daily covid-19 actual log_deaths and predicted log_Deaths for the first Nine months
and forecasted log_Deaths for the next seven days. ................................................................... 55
Figure 20: Comparing daily COVID-19 actual deaths and predicted deaths for the first nine
months and forecasted deaths for the next seven days. ............................................................... 56
Figure 21: Forecast of log_deaths for the ARIMA model (p = 0, d = 1, q = (1, 6, 7)) for the next
7 days of thirteen months’ data with 95% confidence limits. ..................................................... 57
Figure 22: Daily covid-19 actual log_deaths and predicted log_Deaths for the thirteen months and
forecasted log_Deaths for the next seven days ........................................................................... 58
Figure 23: Comparing daily COVID-19 actual deaths and predicted deaths for the thirteen months
and forecasted deaths for the next seven days. ........................................................................... 59
Figure 24: Daily COVID-19 actual Deaths and predicted Deaths for the thirteen months and the
next seven days’ forecasted deaths by ARIMA model (p = 0, d = 1, q = (1, 6, 7)) based on Male.
................................................................................................................................................. 61
Figure 25: Daily COVID-19 actual Deaths and predicted Deaths for the thirteen months and the
next seven days’ forecasted deaths by ARIMA model (p+d = 1, q = (1, 6, 7 )) based on the female.
................................................................................................................................................. 62
Figure 26: COVID-19 log_Cases is shown as a function of the Date ........................................ 64
Figure 27: Autocorrelation Analysis Plots for stationary series of the log_Cases. ...................... 66
x

Figure 28: Forecast of log_ Cases for the ARIMA model (p = 0, d = 1, q = (1, 4, 6 )) for next 7
days first six month’s data with 95% confidence limits.............................................................. 70
Figure 29: First six months’ daily COVID-19 actual log_cases, and predicted and forecasted
log_cases for the next seven days in Florida. ............................................................................. 71
Figure 30: Comparing daily COVID-19 actual deaths and predicted deaths for the first six months
and forecasted Cases for the next seven days. ............................................................................ 72
Figure 31: Forecast of log_Cases for the ARIMA model (p = 0, d = 1, and q = (1, 4, 6 )) for the
next 7 days of the first nine months’ data with 95% confidence limits. ...................................... 73
Figure 32: Daily COVID-19 actual log_Cases and predicted log_Cases for the first Nine months
and forecasted log_Cases for the next seven days ...................................................................... 74
Figure 33: Comparing the daily actual COVID-19 Cases with forecasted COVID-19 Cases for
the first nine months with seven days forecasting value. ............................................................ 75
Figure 34: Forecast of log_Cases for the ARIMA model (p = 0, d = 1, q = (1, 6, 7)) for the next 7
days of the first nine months’ data with 95% confidence limits. ................................................. 77
Figure 35: Daily COVID-19 actual log_Cases and predicted log_Cases for the thirteen months
and forecasted log_Cases for the next seven days ...................................................................... 78
Figure 36: Daily COVID-19 actual Cases and predicted Cases for the thirteen months and
forecasted Cases for the next seven days ................................................................................... 79
Figure 37: Daily COVID-19 actual Cases and predicted Cases for the thirteen months and
forecasted Cases for the next seven days by ARIMA model (p = 0, d = 1, q = (1, 4, 6 )) based on
Male.......................................................................................................................................... 81
Figure 38: Daily COVID-19 actual Cases and predicted Cases for the thirteen months and
forecasted Cases for the next seven days by ARIMA model (p = 0, d = 1, q = (1, 4, 6 )) based on
females...................................................................................................................................... 82
xi

LIST OF TABLES
Table 1: Information of Dataset of COVID-19 in Florida .......................................................... 19
Table 2: List of variables and attributes ..................................................................................... 20
Table 3: Dataset with different variables in the SAS file ............................................................ 21
Table 4: Dataset in sorted based on the Data variable ................................................................ 22
Table 5: Dataset with daily COVID-19 Cases, and Deaths ........................................................ 23
Table 6: Total Number of COVID-19 Cases and Deaths for Female and Male in Florida........... 27
Table 7: Total Number of Cases and Deaths for Male and Female based on Age_group ........... 31
Table 8: Dataset with log-transformed of COVID-19 Cases, and Deaths variables .................... 39
Table 9: Time series procedure- Input Data Set ......................................................................... 41
Table 10: Time series procedure-Variable Information .............................................................. 41
Table 11: Descriptive Statistics for log_Deaths series. ............................................................... 43
Table 12: Autocorrelation Analysis of log_Deaths series. .......................................................... 44
Table 13: Augmented Dickey-Fuller (ADF) Tests ..................................................................... 46
Table 14: SAS recommended ESACF (Extended Sample Autocorrelation Function) Tables for
parameters p, d, and q................................................................................................................ 46
Table 15: Forecast for the ARIMA (p = 0, d = 1, q = (1, 6, 7)) model for log_Deaths variable of
the first six month’s data. .......................................................................................................... 50
Table 16: Forecast for the ARIMA (p = 0, d = 1, q = (1, 6, 7)) model for log_Deaths variable of
the first nine month’s data. ........................................................................................................ 53
Table 17: Forecast for the ARIMA (p = 0, d = 1, q = (1, 6, 7)) model for log_Deaths variable of
thirteen months’ data. ................................................................................................................ 57

xii

Table 18: Evaluation Metrics for the ARIMA Model (p = 0, d = 1, q = (1, 6, 7)) ...................... 60
Table 19: Evaluation Metrics for the developed ARIMA Model for COVID-19 Deaths based on
Gender ...................................................................................................................................... 63
Table 20: Descriptive Statistics for log_Cases series. ................................................................ 65
Table 21: Autocorrelation Analysis of log_Cases series. ........................................................... 65
Table 22: Augmented Dickey-Fuller (ADF) Tests for log_Cases variable.................................. 66
Table 23: SAS recommended ESACF (Extended Sample Autocorrelation Function) Tables for
parameters p, d, and q................................................................................................................ 67
Table 24: Forecast for the ARIMA(p=0, d=1, q=(1, 4, 6 )) model for log_Cases variable of the first
six month’s data. ....................................................................................................................... 69
Table 25: Forecast for the ARIMA (p = 0, d = 1, q = (1, 4, 6 )) model for log_Cases variable of
the first nine month’s data. ........................................................................................................ 73
Table 26: Forecast for the ARIMA (p = 0, d = 1, q = (1, 4, 6 )) model for log_Cases variable of the
first nine month’s data. .............................................................................................................. 76
Table 27: Evaluation Metrics for the developed ARIMA Model for COVID-19 Cases ............. 80
Table 28: Evaluation Metrics for the developed ARIMA Model for COVID-19 Cases based on
Gender ...................................................................................................................................... 83

xiii

CHAPTER 1: BACKGROUND
1.1 Introduction
COVID-19 (Coronavirus disease 2019) is an infectious disease, which is first found at the
end of 2019 in Wuhan, China [1]. COVID-19 leads to severe respiratory syndrome with other
symptoms including acute/light fiver, shortness of breath, cough, muscle pain, headache, fatigue,
and loss of smell and test [2]. In January 2020, the first COVID-19 was confirmed in the United
State. Since the middle of February 2020, COVID-19 has been spreading in the community in the
USA. By April 30, 2021, more than 33.11 million were infected and over 590 thousand died in
the USA [3]. On March 1, 2020, the first two COVID-19 confirm cases were reported in Manatee
and Hillsborough counties of Florida, USA [12]. COVID-19, which is transmitted from person to
person, is primarily spread between people during close contact, small droplets produced by
talking, sneezing, and coughing [4].
In the beginning, the fight against COVID -19 appears to be not under control due to a lack
of deep knowledge, insufficient information, and treatment. As a result, COVID_19 has been
spread so quickly that the number of confirmed cases of COVID-19 and death has been increasing
day by day. COVID-19 has spread nationwide within a month since the first severe acute
respiratory syndrome coronavirus infection in Washington state was confirmed on January 11,
2020, by the US center for disease control and prevention. Although it has been more than one
year since the first COVID 19 case was found in the USA, hundreds of deaths are still occurring
daily all over the USA. Millions of Americans have lost their jobs and many more are only partially
employed, that number could ultimately surpass the great depression, which will take years to
correct.
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To minimize the effect of the COVID-19 pandemic, federal, state, and local governments
responded with various declarations of emergencies, which resulted in travel and entry restrictions.
To slow down the spread of COVID-19, different guidelines and recommendations are imposed,
such as lockdowns, closure of schools, prohibit public gatherings, and imposed other restrictions.
It has been claimed by several recent studies [5,6] that public health interventions, school closure,
cordons sanitaire, traffic restriction, social distancing, stay-at-home order, face-masking all factors
have a link to reduce the daily confirm cases and death of COVID-19. The stay-at-home order was
first started in California on March 19, 2020. Until April 7, the number and proportion of
implementing stay-at-home orders by other 39 states and DC have been increasing. On April 3,
2020, nearly 85.2% of the U.S. population were under Stay-at-home order. [7].

Figure 1: State-mandated stay-at-home orders by date implementation [7].
In response to the COVID-19 pandemic, numerous stay-at-home orders (SAHO), such as
curfew, quarantines, and similar restrictions are enforced locally and nationwide. However, the
2

effect of the state of home order is still unclear due to local factors, such as population densities,
education institutes, businesses, and other local factors [8]. The stay-at-home orders are not
directly correlating with controlling of COVID-19 spreading, which creates opportunities for
researchers to estimate the effect of stay-at-home orders considering local factors, which vary
spatially and temporally.
To face this epidemic (COVID-19), public health experts, policymakers, partisans across
the state, the federal government, and economists are depending on a statistical model to make
predictions and evaluations to stay in a safe situation. Even though several steps have been taken
to control this pandemic, it has not stopped. The current number of Deaths and Cases of COVID19 is decreasing from the end of January 2021. As the different types of vaccines of COVID-19,
such as Pfizer-BioNTech, Moderna, and Johnson & Johnson’s, are now available in the USA, it is
hoped that when most people are fully vaccinated this disease will be controlled. However, it is
not sure whether this number will increase again.
To understand the future condition of COVID-19 Deaths and Cases good models are
needed. There are several time series models for forecasting. However, the most used model is
Autoregressive Integrated Moving Average (ARIMA) model. As the CODIV-19 dataset is a timeseries dataset, using the ARIMA model to forecast the COVID-19 cased and deaths will be a good
choice. It is known that by using SAS software, proc ARIMA’s IDENTIFIED statement will give
some suggestions to choose the best model parameters that will be helpful to forecast. In this study,
we will justify those SAS suggestions based on COVID-19 cases and deaths in Florida.
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1.2 COVID-19 and Current world
COVID-19 is an infectious disease caused by a newly discovered coronavirus 2 (CoV-19).
Mild to moderate respiratory illness (shortness of breath or breathing difficulties, fever, fatigue,
loss of smell, and taste are the most common symptoms with COVID-19 [9]. When an infected
person coughs and sneezes, the droplets of saliva or discharge from the nose spread everywhere
around that person, which is the primary source of COVID-19 spreading. This may also spread
from the touching of contaminated surfaces and then touching the mouth or face. Therefore,
frequent hand washing, social distancing, quarantine, and face covers are recommended by health
experts [10].
COVID-19 vaccination is considered the main resource to help end the COVID-19
pandemic. There are currently three COVID-19 vaccines authorized in the united states for
emergency use: two mRNA vaccines (Pfizer-BioNTech, Moderna) and one viral vector vaccine
(Janssen [Johnson & Johnson]). Even though there are serval vaccines that are approved for
emergency use, COVID-19 is still spreading in the USA. On vaccine trials, more than 70
companies and research teams are working with five and six operating primarily in the united
states.
Figure 2 (a) shows the distribution of COVID-19 confirmed cases worldwide as of week
19 2021 according to the European center for disease prevention and control (ECDC) and (b)
shows the distribution of COVID-19 deaths worldwide as of week 19 2021. It is clear that the
united states still dominating on many death and cases than that of the rest of the world. More than
213 countries and territories around the world are affected by the COVID-19 pandemic.
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(a)

(b)

Figure 2 : (a) Distribution of cases of COVID-19 pandemic and (b) Distribution of COVID-19
deaths worldwide, by continent [11].

1.3 Motivation and Objectives
We are living through a crisis that hasn’t been seen in 100 years. This not a crisis for a
country and territory, it is a world crisis and is created by the COVID-19 pandemic. The impact
and enormous scale of this crisis causing a lot of fear, uncertainty, and anxiety across the whole
world. Researchers are trying to understand the different facts with COVID-19 and trying to bring
5

knowledge to us, which may create a better opportunity to face this pandemic. The main purpose
of this research is two folds: explore COVID-19 cases and deaths in Florida and develop statistical
models for a better understanding of COVID-19 as it relates to the State of Florida. The motivation
of this research are summarized as follows:
1. Florida is one of the most populated states in the United States with more than 21
million populations.
2. The economic impact of Florida is near the top among all states in the USA.
3. Since Florida was hit very badly by the COVID-19 outbreak, this thesis is focused only
on the State of Florida where government data from the Florida Department of Health
(FDOH) is used and the number of cases and deaths are considered main variables to
analyze.
The objectives of this research are summarized as follows:
1. Review literature on modeling efforts of COVID -19 data and identify knowledge
gaps.
2. Collect data from a reliable source.
3. Explore and analyze data to identify and evaluate model performance by using a
data-driven approach using COVID-19 cases and deaths in Florida.

1.4 References

1. Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al. (February 2020). "The
continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest
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CHAPTER 2: LITERATURE REVIEW
2.1 Literature review
An outbreak of novel coronavirus (COVID-19), which began in Wuhan China on
December 31, 2019, and has spread rapidly to most of the countries in the world. According to the
John Hopkins report [1], more than 166 million coronaviruses confirmed cases, and 3.4 million
deaths are counted in worldwide. The World Health Organization (WHO) declared COVID-19 as
a global pandemic on March 11, 2020 [2]. In history, the world has seen several pandemics and
epidemics, including the 1918 Spanish flu, the 1957 Asian flu, and the 1968 Hong Kong flu
pandemics [3].
The most effective way to slow down the spread of the novel coronavirus is to maintain
physical distance from person to person or “socially distance”, which has been recognized by both
World Health Organization (WHO) and the Center for Disease Control (CDC). The initial
response for COVID-19 was slow, although the first confirmed case was reported on January 21,
2020, national wide “state of emergency” was not declared until March 31, which is almost two
months after the first confirmed case in the US [4]. The public health officials are implementing
different orders and warnings, including social distancing, state at home, travel restriction, nonessential businesses, lockdown, and schools, to mitigate the spread of COVID-19.
In the United States, stay-at-home order was announced by California’s Governor in March
2020 for residents to control the outbreak of COVID-19. After that different US states and
territories started implementing community mitigation by the state at home order, which can lower
the risk of disease transmission [5]. In the United States, each state or territory has its laws and
policies to protect the public’s health that widely varied in type and timing of orders issued related
9

to the state-at-home ordered. Therefore, the effectiveness of the state-at-home order varied across
the states and counties, which suggests the spatial and temporal variation for the effectiveness of
the state at home orders and the broader impact of these stay at home orders is still not clear, which
significantly attract researcher to investigate the effectiveness of the stay at home orders locally
and also nationwide.

Figure 3: Florida’s COVID-19 daily cases and deaths from March 24 to April 30, 2021 [6].
Florida is one of the epicenters in the United States, which was hit very badly by the
COVID-19 outbreak [7]. The reason for the higher number of COVID-19 cases could be related
to ports of entry, including shipping ports and airports. Besides that, Florida is a large tourism
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place and has an older age population. Florida has more than 2.2 million COVID-19 cases and
more than 35 thousand deaths until April 2021 [8]. Aric Chokey in his report [6] displays in figure
3, daily reported COVID-19 cases and deaths in Florida from March 24 to April 30, 2021. Florida
gov. issued a state-wide at-home executive order on April 3, 2020, and the first phase of reopening
begins on May 4, 2020. Mask mandates were issued in only a few counties or cities in Florida.
To analysis, the effectiveness of stay-at-home orders, the response measures to the
outbreak of COVID-19, the number of confirmed cases are the most frequently used parameters
in different statistical study studies all over the world [9]. However, the COVID-19 case count is
biased by the number of tests, test equipment, and other factors, therefore, the number of cases is
somewhat not correct.
The COVID-19 pandemic is adding a catastrophic impact in this world, almost every aspect
of our life is affecting by this pandemic. The international statistics community has continued to
work throughout this crisis and ensuring the best quality of data and statistics to support decisionmaking during and after this pandemic. In this study, the number of COVID-19 cases and deaths
are analyzed.
Based on the COVID-19 dataset, many research works have been done and different types
of papers have been published worldwide. Most of those tried to figure out the future condition of
COVID-19. Even though different types of models are used to forecast the COVID-19, the more
frequently used model to this time series data is the ARIMA model. A few of those papers that are
related to current studies of this thesis have been discussed below:
Gecili et al. [11] have forecasted COVID-19 confirmed cases, deaths, and recoveries by
using different time series models. In this research, authors have used four different time series
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models, which are cubic smoothing spline model, Holt model, Autoregressive Integrated Moving
Average (ARIMA) model, and TBATS (Trigonometric Exponential smoothing state space model
with Box-Cox transformation, ARMA errors, Trend, and Seasonal component) model, to forecast
the COVID-19 confirmed cases, deaths, and recoveries and to compare the performance of these
model based on mean absolute error (MAE), mean absolute percentage error (MAPE), and AIC
(Akaike information criteria) by using R software. After analyzing those models, they concluded
that the ARIMA model is the most useful model to do this type of analysis.
Navid Nashinchi has used the time series model in his online article [12] (ARIMA
MODEL) to predict the number of COVID-19 deaths for 21 days and compare the projection with
CNN’s projection. He has used COVID-19 data of the USA from December 31, 2019, to August
01, 2020. To do this analysis he used the R package. In his ARIMA model, the auto.arima function
has suggested three parameters, such as p (autoregressive) = 3, d (integration) = 0, and q (moving
average) = 2. The AIC value of this model is 3129.92 and the BIC value is 3150.11.
Forecasting the future effect of confirmed cases of Coronavirus around the world by using
time series COVID-19 data till June 26, 2020, have presented by Sujeet Maurya. In this aircle[13],
analysis of the COVID-19 data is performed by using Python software with applying four methods,
such as ARIMA, Holt’s Winter seasonal method, NAÏVE, and Holt’s linear trend method. In the
ARIMA model with p = 0, q = 0, and d = 2, their MSE is found to be 7240024855.066816, AIC
value is found to be 2855. The Root Mean Square Error is found to be 16680 for Holt’s linear trend
method, and The Root Mean Square Error is 16789 for Holt’s Winter seasonal method. After
comparing all four models, they conclude that as the MSE for NAÏVE (root mean square error is
15580) is less than other models, therefore it is the best model for their dataset. However, he
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suggested that as the data points are less in their analysis, it could be possible to be another model
with high data points.
Another example of using ARIMA is found in reference [14], where Facebook’s
PROPHET Forecasting Model and ARIMA Forecasting Model have been used to forecast the
trend of the COVID-19 disease in Indonesia and compared those models to get a better performer.
They have forecasted 30 days by applying these two models based on the COVID-19 dataset in
Indonesia that is taken from January 20, 2020, to May 21, 2020. They transformed the data in logscale to do this analysis. For confirmed variable their p = 22, d = 1 and q = 22, for deaths variable
p = 3 and d = 1, and q = 3, and for recovered variable p (AR term) = 1, d (differencing) = 1, and p
(MA term) = 1. In the ARIMA model, the MAE for confirmed Cases, Deaths and Recovered are
found 2967, 617.6, and 961.167, respectively. In the PROPHET model, the MSE is less for each
variable, such as MAE for confirmed Cases, deaths. and recovered are 686.3, 153.1. and 955.83,
respectively. After justifying those two models by using MAE, they concluded that the PROPHET
model is giving more accurate results for their dataset to forecast.
By using the ARIMA model on the COVID-19 data till June 2020 Singh et al. [15]
investigated the prediction forecast for August 2020. The purpose of this study is to find out the
effect of unlocking in India by comparing the forecasted positive cases and the total number of
tests conducted for COVID-19 in unlock and lockdown times. For this analysis, seven forecasting
models, which are TBAT, Prophet, Auto-regressive Integrated Moving Average (ARIMA),
Moving Average, Neural Basis Expansion Analysis (N-BEATS), Single Exponential Method,
Double Exponential Method have been tested and compared based on the prediction accuracy.
After justifying the root mean square error (RMSE), the ARIMA model was selected as the best
forecasting model. In the ARIMA model, the Auto-correlation function (ACF) graph and partial
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autocorrelation (PACF) graph have been used to get P(auto-regression) = 2 for lockdown time and
1 for unlock time, Q (order of moving average) = 2 for lockdown time and 1 for unlocking time,
and D ( degree of trend difference). Dickey-Fuller test has been done to find out whether data is
stationary and log-transformed also has done to get stationery data.
Another research work for forecasting COVID-19 has been done by Omaran et al. [ 16]. In
this paper, the COVID-19 data from May 1, 2020, to December 6, 2020, has been used from three
countries, such as Egypt, Saudi Arabia, and Kuwait. To do this study they used two deep learning
Methods, one is Long short-term memory (LSTM) and gated recurrent unit (GRU). They have
transformed data into two ways supervised learning and scaling. MAE, MAPE, and RMSE
measures have been used to find out the best performer model. In their work, LSTM has shown
the best result in the confirmed cases for those three countries. on the other hand, GRU has given
the best performance in death cases for Egypt and Kuwait.
The above-discussed models are really helpful to know the COVID-19 as they have shown
much information about COVID-19. However, the MAE and AIC values of those previous studies
are not always satisfactory. This can be happened for small size of data or can be happened for the
inaccurate model selection. Therefore, there is a lot of doubt about the accuracy of those models'
results. Since there are numerous available datasets on COVID-19 to avoid that confusion, SAS
suggested selecting the ARIMA model with the best performer parameter (p, d, q) might be helpful.
As SAS is statistical software that helps to analyze advanced data, it has several options to study
with a time-series dataset. In SAS there is an identification option, which will represent different
suggestions to improve the outcomes that are favorable to get the correct ARIMA model.
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CHAPTER 3: DATA COLLECTION AND PREPARATION
3.1 Data Collection
To understand the impact of COVID-19 across the world, accurate data is critical. To find
out the risk factors for this severe disease and transmission, forecast the spread and impact, taking
the proper step, measuring the impact of this disease on society, collection of COVID-19 Data was
urgent. Besides that, to make people aware of the severity and spectrum of illness it is needed to
collect all COVID-19 Data. From appropriate data, the world can have a better understanding,
more appropriate response, estimating, and planning for the future impact of the pandemic like
COVID-19. COVID-19 open-access data and computational resources are being provided by
federal and worldwide agencies, including NIH, WHO, and state departments and private entities.
These resources are freely available to researchers and the public. The most common open-access
data resources are given below
1. Johns Hopkins Coronavirus Resource Center [1].
(https://github.com/CSSEGISandData/COVID19/tree/master/csse_covid_19_data/csse_covid_19_daily_reports_us)
2. World Health Organization (WHO) Coronavirus Disease Dashboard [2]
3. New York Times COVID-19 data [3].
https://github.com/nytimes/covid-19-data/blob/master/us-counties.csv
4. Florida Department of Health data [4]
Florida COVID19 Case Line Data 2020
https://open-fdoh.hub.arcgis.com/datasets/florida-covid19-case-line-data-2020/data

17

Florida COVID19 Case Line Data 2021
https://open-fdoh.hub.arcgis.com/datasets/florida-covid19-case-line-data-2021-1/data
5. Center for Disease Control and Prevention [5]
https://data.cdc.gov/Policy-Surveillance/U-S-State-Territorial-and-County-Stay-AtHome-Orde/qz3x-mf9n/data
As this study focuses on the State of Florida, therefore “Florida Department of Health
Open Data” is used as a source for data in this study. Florida department of health releases a report
each day on the number of new COVID-19 confirmed cases, emergency visits, hospitalizations,
and death [6]. This data includes daily COVID-19 cases and deaths with other related information
at county levels. To collect data and include the most updated information in the analysis, this site
was checked once a week.

3.2 Data preparation
Florida COVID-19 Case Line Data was collected from the Florida Department of Health
Open Data source as a CSV format, where data for 2020 is available as Florida COVID-19 Case
Line

Data

2020

(https://open-fdoh.hub.arcgis.com/datasets/florida-covid19-case-line-data-

2020/data) and data for 2021 is available as Florida COVID-19 Case Line Data 2021 ( https://openfdoh.hub.arcgis.com/datasets/florida-covid19-case-line-data-2021-1/data ). As every day the
number of deaths, cases, hospitalization, and emergency visits are changed, to update the dataset
the page was checked weekly. Data was collected separately from those two links and then
combined to make one dataset. The available data in those links have started from March 2, 2020,
to the current date. The missing data was checked for all dates which are considered in this dataset.
However, it is found that missing data are present only in a few rows. Therefore, to avoid those
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missing values a few rows are omitted from the dataset, which confirmed that in the new dataset
there are no missing values. There were some issues with data with very few or a lot of missing
data before March 12, 2020, thus data from March 12, 2020, to April 30, 2021, have been used.
April 30 has been chosen as a cutoff date to get enough time to finish the analysis and write up the
thesis work.
Table 1: Information of Dataset of COVID-19 in Florida
Dataset Information
First

12MAR2020

Last

30APR2021

Number of days

415

Number of Cases

2237920

Number of Deaths

36909

In this dataset, the total row is 2237922 and there are a total of 12 variables such as County,
Age, Age group, Gender, Edvisit, Hospitalized, Died, Case (Case_), Contact, Case1, EventDate,
and, ChartDate, where 9 variables are character and 3 variables are numeric (Table 2).
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Table 2: List of variables and attributes
Number
1

Variable
Age

Type
Char

Format
$3.00

2

Age_group

Char

$11.00

3

Case1

Num

YYMMDD10.

4

Case_

Char

$3.00

5

ChartDate

Num

YYMMDD10.

6

Contact

Char

$7.00

7

County

Char

$12.00

8

Died

Char

$3.00

9

EDvisit

Char

$7.00

10

EventDate

Num

YYMMDD10.

11

Gender

Char

$7.00

12

Hospitalized

Char

$7.00

To analyze this large data set, commercially available statistical software “SAS” is used.
SAS Proc import datafile command is used to import the data in the SAS file. As mentioned earlier
that the original dataset was downloaded as CSV. Table-3 shows the part of the dataset that
represents different variables.
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Table 3: Dataset with different variables in the SAS file
County

Age

Age_group

Gender

EDvisit

Volusia

51

45-54 years

Male

NO

Dade

47

45-54 years

Male

Dade

39

35-44 years

Collier

12

Hillsbor
ough

Hospitalized
NO

Death
s
NA

Case
s
Yes

NO

NO

NA

Female

NO

NO

5-14 years

Female

NO

55

55-64 years

Female

Volusia

21

15-24 years

St. Lucie

62

Polk

Case1

EventDate

ChartDate

2020-04-15

2020-03-23

2020-04-15

Yes

2020-04-15

2020-04-01

2020-04-15

NA

Yes

2020-12-31

2020-12-31

2020-12-31

NO

NA

Yes

2020-11-02

2020-11-02

2020-11-02

NO

NO

NA

Yes

2020-10-26

2020-10-26

2020-10-26

Female

UNKNOW
N

UNKNOWN

NA

Yes

2020-10-26

2020-10-26

2020-10-26

55-64 years

Male

NO

NO

NA

Yes

2020-10-26

2020-10-26

2020-10-26

21

15-24 years

Male

UNKNOW
N

UNKNOWN

NA

Yes

2020-10-26

2020-10-26

2020-10-26

Dade

10

5-14 years

Male

NO

NO

NA

Yes

2020-10-26

2020-10-24

2020-10-26

Orange

16

15-24 years

Female

NO

NO

NA

Yes

2020-11-05

2020-11-03

2020-11-05

In the main dataset variables “Jurisdiction”, “Travel_related”, “Origin”, “Contact” and
“ObjectId” are included. However, those variables have been dropped from the original dataset as
these variables are not considered for analysis and a new dataset is created. After eliminating these
variables from the original dataset, the dependent variable will not be affected. In this dataset,
dates are presented based on three types of dates, which are Case1, EventDate, and ChartDate.
However, Case1 is considered as the exact date of the COVID-19 case. Therefore, the name of the
variable “Case1” is changed to “Date”.
In the original dataset, data are imputed randomly with a different date. Therefore, it has
been sorted by the “Date” variable to represent the data in a more organized way that will help to

21

understand data easily. Since there are 22,37,922 rows in this dataset, only ten among them are
shown in table-4, which started on March 12, 2020.
Table 4: Dataset in sorted based on the Data variable
County
St. Johns

Age
63

Age_group
55-64 years

Gender
Male

EDvisit
YES

Hospitalized
YES

Deaths
NA

Cases
Yes

Date
2020-03-12

Broward

70

65-74 years

Male

YES

YES

Yes

Yes

2020-03-12

Lee

57

55-64 years

Male

NO

NO

NA

Yes

2020-03-12

Broward

65

65-74 years

Male

NO

NO

NA

Yes

2020-03-12

Broward

61

55-64 years

Male

YES

NO

NA

Yes

2020-03-12

Dade

56

55-64 years

Male

YES

NO

NA

Yes

2020-03-12

Seminole

68

65-74 years

Male

YES

NO

NA

Yes

2020-03-12

Palm Beach

73

65-74 years

Male

YES

YES

Yes

Yes

2020-03-13

Broward

20

15-24 years

Female

YES

YES

NA

Yes

2020-03-13

Duval

83

75-84 years

Male

YES

YES

Yes

Yes

2020-03-13

Then a dataset has been created by using the total count of Cases, and Deaths against each
date to do more analysis. An id variable is also created to make analysis easier. There is a total of
415 rows and 4 columns in this dataset that is shown in table 5, where only a few rows are
presented.
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Table 5: Dataset with daily COVID-19 Cases, and Deaths
Date
2020-03-12

Cases
7

Deaths
1

id
1

2020-03-13

24

5

2

2020-03-14

45

2

3

2020-03-15

33

4

4

2020-03-16

31

4

5

2020-03-17

70

4

6

2020-03-18

107

7

7

2020-03-19

87

5

8

2020-03-20

150

11

9

2020-03-21

217

15

10

2020-03-22

306

17

11

2020-03-23

193

16

12

2020-03-24

299

20

13

2020-03-25

515

33

14

2020-03-26

560

27

15

2020-03-27

689

59

16

2020-03-28

728

43

17

2020-03-29

909

57

18

2020-03-30

897

55

19

2020-03-31

937

42

20

23

3.3 References
1. Johns Hopkins Coronavirus Resource Center. Retrieved 2020-10-18.
2. WHO Coronavirus Disease (COVID-19) Dashboard, covid19.who.int. Retrieved 2020-1018.
3. New York Times coronavirus data. Retrieved 2020-10-18. https://github.com/nytimes
4. Florida Department of Health Open data. Retrieved 2020-10-18.
https://open-fdoh.hub.arcgis.com/
5. Central for Disease Control and Prevention. https://data.cdc.gov/
6. CDC, Men and COVID-19: A Biopsychosocial Approach to Understanding Sex
Differences in Mortality and Recommendations for Practice and Policy Interventions,
Commentary, Vol. 17, July 16(2020).
https://www.cdc.gov/pcd/issues/2020/20_0247.htm#:~:text=According%20to%20the%20
largest%20body,fatality%20ratio%20is%20approximately%202.4
7. Jeffrey E. Harris, Data from the COVID-19 epidemic in Florida suggest that younger
cohorts have been transmitting their infections to less socially mobile older adults,
Springer, August 2020.

24

CHAPTER 4: DATA DESCRIPTION
4.1 Descriptive Analysis
The daily cases and deaths in Florida from March 12, 2020, to April 30, 2021, are
calculated using SAS PROC FREQ. There were 2237920 cases and 36909 deaths during the
period mentioned above. The daily number of cases is displayed below.

Figure 4: Daily COVID-19 cases from March 12, 2020, to April 30, 2021, in Florida

Figure 4 shows the daily number of COVID-19 cases in Florida. In this figure, there are 4
peaks. The first peak happened in April 2020, the second peak was in July 2020, the third peak
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that is the highest peak until April 30, 2021, was in January 2021, and the fourth peak was in April
2021.
Similarly, the frequency analyses were performed for daily deaths and are displayed below:

Figure 5: Daily COVID-19 deaths from March 2020 to April 2021 in Florida
Figure 5 shows daily COVID-19 deaths in Florida. From this figure, it can be seen that the
highest number of deaths was happening in July 2020. In this figure, there are three peaks for daily
COVID-19 deaths. The first peak was in April 2020, the second peak was in July 2020, and the
third peak was in January 2021.
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CDC reported that male patients are dying more than female patients for COVID-19
disease worldwide [1]. Florida data also suggested that the number of deaths for male patients is
higher than that of females for COVID-19, even though the number of cases is higher for female
patients compared to male. In table 6, it is shown that the total number of cases for females is
1168825 and that for males is 1049716 whereas the total number of deaths of females is 16153
and males are 20756 from March 12, 2020, to April 30, 2021.
Table 6: Total Number of COVID-19 Cases and Deaths for Female and Male in Florida

Gender

Cases

Deaths

Female

1168825

16153

Male

1049716

20756

Unknown

19379

0

To explore further how gender relates to deaths and cases here in Florida, the daily cases
and deaths are displayed by gender in the following plots:
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Figure 6: Daily COVID-19 cases of male and female in Florida
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It can be seen from this figure 6 that even though some of the point the number of cases
for both genders overlap, most of the time daily COVID-19 cases of the female are more than that
of male in Florida. So, not only the total number of COVID-19 cases is higher for females but
also the daily number of COVID-19 cases is higher for them than that of males in Florida.
Therefore, females are more affected by COVID-19 compare to males in Florida.
As the overall COVID-19 deaths are high for male patients, to see the daily COVID-19
deaths in Florida the plots of Date variable vs Deaths variable based on gender have been drowned.
From this daily COVID-19 deaths plot, it is seen that in most of the cases the daily deaths for
COVID-19 male patients are more than that of COVID-19 female patients (Figure 7).
After observing those two plots (Figure 6 and Figure 7) it is clear that the total number of
cases and deaths in Florida are showing different results. Even though the number of daily COVID19 cases is confirmed more for females, the number of deaths of daily COVID-19 is higher for
males in Florida.
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Figure 7: Daily COVID-19 deaths of male and female in Florida
30

Table 7 displays the cases and deaths by both age group and gender. It appears that females
between 25 and 34 years are affected more than any other age group. However, the number of
deaths for male patients is highest (6507) in the age group 75 to 84.
Table 7: Total Number of Cases and Deaths for Male and Female based on Age_group
Age_group

Gender

Cases

Deaths

Female

22504

1

Male

23912

1

Female

71970

4

Male

73416

1

Female

184835

24

Male

162237

28

Female

206101

91

Male

183137

135

Female

182850

225

Male

162040

381

Female

176829

542

Male

159349

973

Female

150906

1538

Male

138399

2623

Female

92681

3052

Male

84248

4887

Female

51590

4645

Male

45594

6507

Female

28046

6031

Male

16813

5220

Female

513

0

Male

571

0

0-4 Years

5-14 Years

15-24 Years

25-34 Years

35-44 Years

45-54 Years

55-64 Years

65-74 Years

75-84 Years

85+ Years

Unknown
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Figure 8: COVID-19 cases for male and female based on different Age_group
When the number of cases of COVID-19 patients vs Age_group based on gender plot is
drowned, it is seen that the female whose age is in 25-34 Age_group are confirmed more COVID19 cases than other groups, which is shown in figure 8.
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Figure 9: COVID-19 deaths for male and female based on different Age_group
Figure 9 displays that the number of deaths of COVID-19 is increasing for male and female
patients with increasing of ages. The male patients, whose age is between 75 and 84, were dead
for COVID-19 more than other groups. Therefore, males deaths across all ages are high.
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CHAPTER 5: METHODS AND MODEL
5. 1 Time series ARIMA model
A sequence of data on an outcome variable of interest observed at successive equally
spaced points in time is referred to as time-series data. The time-series data considered in this
thesis consists of daily counts of cases and deaths due to Covid-19 in the State of Florida from
March 12, 2020, to April 30, 2021.
The time series modeling approach, proposed by Box and Jenkins (1970), is used to predict
a value in a stationary response time series {Yt, t = 1, 2, … n} as a linear combination of its past
values, past errors, and current and past values of related other time series. More specifically, this
modeling approach combines an autoregressive model AR(p) and a
MA(q)

moving average model

where AR(p) uses p-lagged values of the outcome variable for predictions and MA(q)

uses the series mean and q-lagged errors for predictions. These two models are displayed below.
AR(p) Model:
𝑦𝑡 = 𝑘 + ∅1 𝑦𝑡−1 + ∅2 𝑦𝑡−2 + ∅3 𝑦𝑡−3 + ⋯ + ∅𝑃 𝑦𝑡−𝑝 + 𝜀𝑡

(1)

In the above AR(p) model, k is the constant, 𝑦𝑡−1 , 𝑦𝑡−2 , 𝑦𝑡−3 , and 𝑦𝑡−𝑝 are p lagged values of
the outcome variable Yt with corresponding parameters ∅1 , ∅2 , …, ∅𝑝 , and 𝜀𝑡 is the white noise.
MA(q) Model:
𝑦𝑡 = 𝑐 + 𝜀𝑡 − 𝜃1 𝜀𝑡−1 − ⋯ − 𝜃𝑞 𝜀𝑡−𝑞
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(2)

In the moving average MA(q) model, 𝑦𝑡 is considered as a weighted average of the past q
forecast errors and c is the expectation of the series (𝑦𝑡 ), 𝜃1 , … … , 𝜃𝑞 are the parameters of the
model and 𝜀𝑡 , 𝜀𝑡−1 …, 𝜀𝑡−𝑞 are white noise error terms. The combined AR(p) and MA(q) model
referred to as ARMA(p,q) model may be displayed as follows:
𝑦𝑡 = 𝜇 + ∅1 𝑦𝑡−1 + ⋯ + ∅𝑝 𝑦𝑡−𝑝 + 𝜀𝑡 − 𝜃1 𝜀𝑡−1 − ⋯ − 𝜃𝑞 𝜀𝑡−𝑞

(3)

In ARMA(p, q) model (3), the predictors consist of lagged values of the dependent variable
as well as lagged forecast errors and thus the predicted value of outcome variable Y is a weighted
sum of p recent values of Y and q recent values of the errors. However, the above model is
appropriate whenever the time series is stationary. Note that a time series is said to be stationary
if its mean, variance, autocorrelation, etc., remain constant over time.

If a time series is

nonstationary, then often differences are taken to achieve stationarity, and then the ARMA model
is used on the differenced values Zt (say) of the time series (simply replace yt by zt in the model
(3)). The resulting model is then referred to as the autoregressive integrated moving average
(ARIMA(p, d, q)) model where d is the number of differences used to achieve stationarity.
Proc ARIMA developed by SAS provides a comprehensive set of tools for univariate time
series model identification, parameter estimation, and forecasting. In this thesis, we have utilized
Proc ARIMA’s

“IDENTITY” statement

for model identification and

“FORECAST” for

forecasting using the following steps:
•

Check stationarity using rolling mean and rolling standard deviation, and Augmented
Dickey-Fuller (ADF) Tests

•

Transform data to achieve stationarity
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•

Use PROC ARIMA (p, d, q) on transformed data to identify appropriate values of p,
d, and q using IDENTIFY statement

•

Use model comparison criteria AIC, SBC to choose a given set of values of p, d, and
q for the forecast model that appear to be a good fit for our data

•

Find model coefficients that provide the best fit for our data.

•

Test the models’ assumptions.

•

Compare model with previously known models by using MAE

•

Use the chosen model for forecasting.

These steps are discussed below in more detail using COVID-19 Cases and Deaths data
reported by the Florida Department of Health from March 12, 2020, to April 30, 2021.

5. 2 Strategy for developing the ARIMA model of COVID-19 data in Florida
In this study, the performance of proc ARIMA’s identify statement has been evaluated,
where forecasting of the COVID-19 Deaths and Cases has been also done.
Time series data can be stationary or nonstationary, therefore it needs to figure out that our
data is stationary or non-stationary. In addition, the ARIMA model requires to have stationary
form, which is also required to check stationarity before using the ARIMA model. When the mean
and variance of data are constant over time that means the data has stationarity. The 7 days rolling
mean and standard deviation have been performed in this study to check stationarity as reported in
different articles on COVID-19 data [2]. After performing a rolling mean and standard deviation
for 7- days, non-stationarity has been observed, which are shown in Figures 10(a) and 10(b).
Figure 10(a) shows the rolling mean and standard deviation data for the number of COVID-19
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cases and Figure 10(b) shows the rolling mean and standard deviation for the number of COVID19 deaths.

Figure 10: (a) The rolling mean and standard deviation of the number of COVID-19 cases and(b)
The rolling mean and standard deviation of the number of COVID-19 deaths
From figure 10(a,b) it can be concluded that the mean and variance of COVID-19 cases
and deaths are not constant and both go ups and down over time. Therefore, this time series data
is not stationary.
There are different ways to make the time-series data stationary, where log transformation
of data can provide constant variance, and differencing (different between consecutive
observations) can give constant mean [3]. Therefore, the log-transformed has been performed in
this study to get data with constant variance. Some part of this log-transformed dataset has been
given in table 8.
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Table 8: Dataset with log-transformed of COVID-19 Cases, and Deaths variables
Date
2020-03-12

Cases
7

Deaths
1

id
1

Log_Cases
1.94591

Log_Deaths
0.00000

2020-03-13

24

5

2

3.17805

1.60944

2020-03-14

45

2

3

3.80666

0.69315

2020-03-15

33

4

4

3.49651

1.38629

2020-03-16

31

4

5

3.43399

1.38629

2020-03-17

70

4

6

4.24850

1.38629

2020-03-18

107

7

7

4.67283

1.94591

2020-03-19

87

5

8

4.46591

1.60944

2020-03-20

150

11

9

5.01064

2.39790

2020-03-21

217

15

10

5.37990

2.70805

2020-03-22

306

17

11

5.72359

2.83321

2020-03-23

193

16

12

5.26269

2.77259

2020-03-24

299

20

13

5.70044

2.99573

2020-03-25

515

33

14

6.24417

3.49651

2020-03-26

560

27

15

6.32794

3.29584

2020-03-27

689

59

16

6.53524

4.07754

2020-03-28

728

43

17

6.59030

3.76120

2020-03-29

909

57

18

6.81235

4.04305

2020-03-30

897

55

19

6.79906

4.00733

2020-03-31

937

42

20

6.84268

3.73767

Transforming COVID-19 data in the log-transformation format, it is found that the variance
is approximately constant. Figures 11(a) and 11(b) are showing the rolling mean and standard
deviation for the logarithm of COVID-19 cases and deaths, respectively. It is obvious from figure
11 (a,b) that the mean for the logarithm of COVID-19 cases and deaths are both not constant.
Therefore, to get consistency differencing (period of differencing = 1) has been done.
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Figure 11: (a) the rolling mean and standard deviation for the logarithm of COVID-19 cases, and
(b) the rolling mean and standard deviation for the logarithm of COVID-19 deaths.
After differencing the COVID-19 data, it can be seen that the mean and variance are close
to being constant. In figures 12 (a) and 12 (b) are representing the rolling mean and standard
deviation for one difference of the COVID-19 log_cases and log_deaths, respectively

Figure 12: (a) the rolling mean and standard deviation for the COVID-19 log_Cases, and (b) the
rolling mean and standard deviation for the COVID-19 log_Deaths after differencing the data (
the period of difference = 1)
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However, to get a clear scenario of the stationarity of COVID-19 data more analysis has
been done by using proc arima procedure, which will be discussed below. The outputs of
log_Cases and log_Deaths variables by using the time-series model (ARIMA model) will be
discussed separately in this part. At first, the finding results of the log_death variable are given.
Table 9: Time series procedure- Input Data Set
Input Data Set
Name

WORK. LOG_COVID_19

Label
Time ID Variable

Date

Time Interval

DAY

Length of Seasonal Cycle

7

Table 9 represents the name of the dataset that is log_COVID_19, where the Time ID Variable is
Date, and the Time Interval is Day with seven seasonal Cycle.
Table 10: Time series procedure-Variable Information
Variable Information
Name

Log_Deaths

Label
First

12MAR2020

Last

30APR2021

Number of Observations Read

415

In this time series analysis, the used variable is log_Deaths (log-transformed of Deaths
variable) and a total of 415 observations is considered. A plot has been shown below with logtransformed Deaths variable against Date variable.
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Figure 13: Log_Deaths is shown as a function of the Date
Figure 13 shows daily COVID-19 log_Deaths in Florida, where the highest peak was in
January 2021. There are three stages of ARIMA modeling, such as identification stage, estimation
and diagnostic checking stage, and forecasting stage. All of these stages are discussed one by one.

5. 3 Model Identification for log_Deaths variable
IDENTIFY statements can be used to specify the response series and find out possible
candidates for ARIMA models, where this statement is used to read the log_Deaths series and
analyze its correlation properties in this study. In the identification stage, log_Deaths series are
changed from nonstationary to stationary by one period of differencing. After using the period of
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differencing 1, the mean of the log_Deaths series is 0.006697 that is close to zero and the standard
deviation is 0.352396 (table 11).
Table 11: Descriptive Statistics for log_Deaths series.
Name of Variable = log_Deaths
Period(s) of Differencing

1

Mean of Working Series

0.006697

Standard Deviation

0.352396

Number of Observations

414

Observation(s) eliminated by differencing

1

In the identification stage, the white noise of time series data has been done as it is not
possible to build a time series model with white noise. To check white noise a hypothesis test has
been used. The results are described below:
Null Hypothesis:

log_Deaths series data with white noise;

Research Hypothesis:

log_Deaths series data without white noise;

In this case, the white noise hypothesis is rejected rigorously. As the p-value for the test of
the first six autocorrelations is <0.0001, which means that the p-value is less than alpha 0.05. So,
the null hypothesis is rejected. Therefore, this time series data is without white noise. So, building
a time series model with these data is possible.
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Table 12: Autocorrelation Analysis of log_Deaths series.
Autocorrelation Check for White Noise
To Lag Chi-Square DF Pr > ChiSq

Autocorrelations

6

70.02

6

<.0001 -0.401

0.015 -0.041 -0.070

12

113.36

12

<.0001

18

167.62

18

<.0001 -0.128

0.285

0.017 -0.103

24

180.52

24

<.0001 -0.004

0.062

0.134

0.022 -0.011

0.263 -0.010 -0.045 -0.032 -0.124

0.120

0.014 -0.131

0.020 -0.038 -0.076

In the ARIMA procedure, IDENTIFY statements normally generate some plots, such as
the time series plot of the series, the sample autocorrelation function plot (ACF), the sample
inverse autocorrelation function plot (IACF), and the sample partial autocorrelation function plot
(PACF). Among them, the ACF plot is used to determine whether the dataset is stationary or nonstationary, and the Augmented Dickey-Fuller (ADF) tests are also done to find out whether data
is stationary or nonstationary.
In Figure 14, it has been shown that ACF does not decay slowly rather than the
autocorrelations in the ACF plot changes rapidly. Thus, the series of log_Deaths is considered
approximately stationary data.
To be more confirm that the series of log_Deaths is stationary data, the Augmented
Dickey-Fuller (ADF) test has been performed.
From table 12 the p-values of the tau test, Rho test, and F test for all three models, such as
zero mean, single mean, and trend are less than 0.05. So, the series appears stationary.
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Figure 14: Autocorrelation Analysis Plots for stationary series of the log_Deaths.
The Extended Sample Autocorrelation Function (ESACF) table that recommends different
values for parameters, p (the order of the Autoregressive model), d (the order of the differencing)
and q (the order of the Moving Average model) based on the significance level specified by the
ALPHA = 0.05 has been considered in this analysis to get one or more ARIMA models by using
esacf option in the IDENTIFY statement. Then the performances of those recommended
parameters have been evaluated by using the first six month’s data and forecasting the next 7 days’
data, nine month’s data and forecasting the next 7 days’ data, and then all reported FDOH data
from March 12, 2020, to April 30, 2021, and forecasting the future data.
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Table 13: Augmented Dickey-Fuller (ADF) Tests
Augmented Dickey-Fuller Unit Root Tests
Type

Lags

Rho

Pr < Rho

Tau

Pr < Tau

0

-578.322

0.0001

-31.99

<.0001

1

-811.190

0.0001

-20.25

<.0001

0

-578.445

0.0001

-31.96

1

-812.395

0.0001

0

-580.543

1

-830.794

Zero Mean

Single Mean

Trend

F

Pr > F

<.0001

510.67

0.0010

-20.24

<.0001

204.75

0.0010

0.0001

-32.08

<.0001

514.58

0.0010

0.0001

-20.44

<.0001

208.92

0.0010

Table 14: SAS recommended ESACF (Extended Sample Autocorrelation Function) Tables for
parameters p, d, and q.
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Table 14 shows SAS suggestion of the following parameters to fit one or more ARIMA
models for the first six months’ data, nine months’ data, and from March 12, 2020, to April 30,
2021 data in Florida.

5.4 Estimation and diagnostic checking for log_Deaths variable
ESTIMATE statement has been used to specify the ARIMA model to fit log-Deaths
variable and to estimate the best parameters of that model. The recommendation for parameters
(p, d, and p) specified in the previous IDENTIFY statement has been justified in this stage. As the
period of differencing 1 has been used to make data stationery, the first recommendation of the
ESACF table, (p+d, q) = (0,7), has been ignored. Then different models with those suggested
parameters of ESACF tables have been fitted and compared with each other based on AIC (Akaike
Information Criterion) values, SBC (Schwarz Bays Criterion) values, and convergency problems
for approximately six months’ data (from March 12, 2020, to September 10, 2020), for
approximately 9 months’ data (from March 12, 2020, to December 09, 2020), and for
approximately 13 months data (from March 12, 2020, to April 30, 2021) of Florida. In each case,
p+d = 1 and q = 7 has been performing the best across all recommended parameters of ESACF
tables.
After building models with parameters p+d = 1 and q = 7, significant parameters of those
models at alpha 0.05 have been found by observing the Maximum Likelihood Estimation tables
that are produced by the ESTIMATE statement. From the Maximum Likelihood Estimation table,
it has been seen that the MA1,1; MA1,6; and MA1,7 are significant parameters at alpha 0.05 as
their p-values are less than 0.05 for 9 months’ data (from March 12, 2020, to December 09, 2020),
and 13 months data (from March 12, 2020, to April 30, 2021) of Florida. However, for the first six
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months’ data (from March 12, 2020, to September 10, 2020) MA1,1; and MA1,7 are only
significant at alpha 0.05. As including MA1,6 in the model provides smaller AIC and SBC values
and improves the overall performance of the model, it has been kept. Therefore, p=0, d = 1 and q
= (1, 6, 7) parameters are used to build these models. For the Chosen ARIMA model of six months,
nine months, and thirteen months, the fitting of a constant parameter is suppressed as the constant
term has been added little to the model.
The three fitted equations of ARIMA model (p = 0, d = 1, q = (1, 6, 7) for COVID-19
log_Deaths are shown below, where zt is the predicted value of log(yt) – log(yt-1):
Six months
𝑧𝑡 = 𝑒𝑡 − 0.5231 𝑒𝑡−1 + 0.0997𝑒𝑡−6 + 0.26361 𝑒𝑡−7

(4)

Nine months
𝑧𝑡 = 𝑒𝑡 − 0.59242 𝑒𝑡−1 + 0.14668 𝑒𝑡−6 + 0.19463 𝑒𝑡−7

(5)

Thirteen months
𝑧𝑡 = 𝑒𝑡 − 0.62506 𝑒𝑡−1 + 0.13609 𝑒𝑡−6 + 0.1714 𝑒𝑡−7

(6)

To know whether the model is fully adequate for those series, the autocorrelation of
residuals has been checked. As the p-values of the first six lags are higher than the alpha value
0.05, the null hypothesis-no-autocorrelation hypothesis is not rejected for all three periods of
models (first six months, nine months, and thirteen months). Therefore, the ARIMA models with
parameters (p = 0, d = 1, and q = (1, 6, 7)) are adequate to do this analysis. To be more confirm
the graphical checks have also been done. Normality of residual has also been checked by using
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normality plots that represent that there is no departure from normality for this ARIMA model (p
+d = 1, q = (1, 6, 7)) for all three periods of models.

5.5 Forecasting for COVID-19 log_Deaths

By using the developed ARIMA model, log_Deaths of COVID-19 in Florida within seven
days have been forecasted. To forecast this short-term future values of deaths series, the
FORECAST statement has been used for the model with the first six months data, the nine months
data, and thirteen months data. SAS given results for those months' models are discussed one by
one.
5.5.1 First Six Months

FORECAST statement gives the next 7 days' forecasted values with standard error and
95% confidence limits for the forecast. Table 15 represents the forecasted seven days’ values,
where it can be seen that even though the number of log_Deaths would decreasing for some days,
the number of log_Deaths would be increasing again.
In figure 15, it is obvious that the ARIMA model (p = 0, d = 1, q = (1, 6, 7)) predicted the
number of log_deaths would be decreasing till September 14, 2020, then the number of log_deths
would be increasing.
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Table 15: Forecast for the ARIMA (p = 0, d = 1, q = (1, 6, 7)) model for log_Deaths variable of
the first six month’s data.
Forecasts for variable log_Deaths for First Six months
Obs

Forecast

Std Error

95% Confidence Limits

184

4.2286

0.2918

3.6566

4.8006

185

4.1204

0.3233

3.4867

4.7541

186

4.0428

0.3520

3.3529

4.7327

187

3.9260

0.3785

3.1841

4.6678

188

4.0435

0.4033

3.2531

4.8340

189

4.1124

0.4266

3.2762

4.9486

190

4.1560

0.4586

3.2572

5.0549

Figure 15: Forecast of log_Deaths for the ARIMA model (p = 0, d = 1, q = (1, 6, 7)) for next 7
days first six month’s data with 95% confidence limits.
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Then daily’s actual log_Deaths and predicted log_Deaths have been compared from March
12, 2020, to September 10, 2020, where the next seven day’s forecasted number of log_deaths is
shown in Figure 16 (a). Here, the figure shows that actual values and predicted values support each
other with very minimum error.

Figure 16: Daily covid-19 actual log_Deaths and predicted log_Deaths for the first six months
and forecasted log_Deaths for the next seven days in Florida.
To see a better picture of COVID-19 deaths for the first six months with seven days of
forecasting, figure 17 has been done without log-transformed values of Deaths.
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Figure 17: Comparing daily COVID-19 actual deaths and predicted deaths for the first six
months and forecasted deaths for the next seven days.
In the previous figure, it has been shown that the ARIMA model (p = 0, d = 1, q = (1, 6,
7)) forecasted that the deaths would be decreasing until September 14, 2020, and would be
increasing till September 17, 2020. To justify this model’s forecasting the actual number of deaths
from March 12 to September 17 has been used. Figure 18 shows both actual deaths, and forecasted
deaths, which are supported each other. Therefore, this indicates developed model has been
forecasted sufficiently for the short-term duration (seven days).
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5.5.2. FIRST Nine months:

As shown previously, similar work has been done for Nine months duration. ARIMA (p =
0, d = 1, q = (1, 6, 7)) model of nine months gives the forecasted values of the log_Deaths for the
next seven days that are given below:
Table 16: Forecast for the ARIMA (p = 0, d = 1, q = (1, 6, 7)) model for log_Deaths variable of
the first nine month’s data.
Forecasts for variable log_Deaths for Nine Months
Obs

Forecast

Std Error

95% Confidence Limits

274

5.1301

0.3009

4.5405

5.7198

275

5.1656

0.3249

4.5288

5.8023

276
277

5.0872
4.9996

0.3473
0.3683

4.4066
4.2778

5.7678
5.7214

278

4.9673

0.3882

4.2066

5.7281

279

5.0613

0.4071

4.2635

5.8591

280

5.1525

0.4399

4.2904

6.0147

From table 16 is obvious that even though the number of COVID-19 log_Deaths was
decreasing until December 14, 2020, that was starting to increase again. The same things are shown
in figure 18.
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Figure 18: Forecast of log_deaths for the ARIMA model (p = 0, d = 1, q = (1, 6, 7)) for the next
7 days of the first nine months’ data with 95% confidence limits.
For Nine months' durations, it is also shows developed ARIMA model has predicted the
number of COVID-19 deaths fairly enough. In figure 19, the log number of COVID-19 deaths of
actual and predicted values are shown for nine months duration, and also included 7 days
forecasting based on the developed model, which is developed from the nine months actual data.
The forecasting values are shown with blue dash lines in the figure.
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Figure 19: Daily covid-19 actual log_deaths and predicted log_Deaths for the first Nine months
and forecasted log_Deaths for the next seven days.
In figure 20, the number of COVID-19 deaths of actual and predicted values are shown for
Nine months duration without log values and also 7 days of forecasting data, where the comparison
between the actual value and forecast value are represented with green dash lines. As mentioned
above, these forecasted values are obtained from the developed ARIMA model suggested by SAS,
and this model is based on the first nine months' data. For nine months of data, it is found that the
developed model in this study has been able to forecast short-term duration well enough that
supported with actual value.
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Figure 20: Comparing daily COVID-19 actual deaths and predicted deaths for the first nine
months and forecasted deaths for the next seven days.
5.5.3 Thirteen months:
Now the seven days’ forecasted values that are gotten by the developed ARIMA model are
shown in table 17, where it can be seen that the COVID-19 log_Deaths are decreasing. Figure 22
also represents that the COVID-19 log_deaths are decreasing.
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Table 17: Forecast for the ARIMA (p = 0, d = 1, q = (1, 6, 7)) model for log_Deaths variable of
thirteen months’ data.
Forecasts for variable log_Deaths for Thirteen Months
Obs

Forecast

Std Error

95% Confidence Limits

416

2.7682

0.2877

2.2043

3.3322

417

2.7409

0.3073

2.1386

3.3432

418

2.7849

0.3257

2.1465

3.4232

419

2.8147

0.3431

2.1422

3.4871

420

2.7460

0.3596

2.0411

3.4509

421

2.6463

0.3755

1.9104

3.3823

422

2.6148

0.4032

1.8245

3.4052

Figure 21: Forecast of log_deaths for the ARIMA model (p = 0, d = 1, q = (1, 6, 7)) for the next
7 days of thirteen months’ data with 95% confidence limits.
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For thirteen months duration, like previous work, the same work has been done by
considering the developed ARIMA model (p = 0, d = 1, q = (1, 6, 7)).

Figure 22: Daily covid-19 actual log_deaths and predicted log_Deaths for the thirteen months
and forecasted log_Deaths for the next seven days
Figure 22 represents the log number of COVID-19 deaths of actual and predicted values
for thirteen months duration with seven days forecasting based on the developed ARIMA model.
Then to see the results more clearly figure 24 has been drowned, where without log data has been
taken. In figure 23, a comparison of daily COVID-19 actual deaths and predicted deaths for the
thirteen months with forecasted Cases for the next seven days has been shown, where it is obvious
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that the actual deaths would be decreased after April 30, 2021, and the developed model also
forecasted that the next seven days’ deaths would decrease.

Figure 23: Comparing daily COVID-19 actual deaths and predicted deaths for the thirteen
months and forecasted deaths for the next seven days.
Now to compare these three models, more analysis has been done using MAE (Mean
Absolute Error) and RMSE (Root Mean Squared Error). In table 18, MAE values and RMSE
values are given for six months, nine months, and thirteen months duration. However, when other
journals have been reviewed, it is found [4] that MAE is 617.6 and MSE is 388366.67 by using
the ARIMA model (p+d = 4, q = 3). Therefore, MAE and RMSE values for all three models are
comparatively low than recently published work for those kinds of studies. As shown before, all
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three models are forecasted the number of COVID-19 deaths for a short-term duration, which is 7
days in this study, quite enough to do further analysis.
Table 18: Evaluation Metrics for the ARIMA Model (p = 0, d = 1, q = (1, 6, 7))
Evaluation Metrics for the ARIMA Model (p = 0, d = 1, and q = (1, 6, 7))
for COVID-19 Deaths
Six Months

Nine Months

Thirteen Months

Mean Absolute Error (MAE)

20.22

21.26

17.84

Root Mean Squared Error
(RMSE)

30.62

36.40

25.56

Satrio et al [4] Found in their study that MAE is 617.6 and MSE is 388366.67 (or equivalent
Root Mean Squared Error = 623.19) by using the ARIMA model (p+d = 4, q = 3) for COVID19 deaths.

Therefore, it can be said that the MAE and RMSE found for proposed models in this
analysis are lower than those found elsewhere in the literature.
Previously shown that the total number of COVID-19 Deaths for males is higher than that
of females, and the daily deaths are also mostly higher for males. Now to see the effect of gender
in forecasted COVID-19 deaths, the fitted ARIMA model (p = 0, d = 1, q = (1, 6, 7)) for log_Deaths
has been fitted again based on gender, where this developed model is fitted for male and female
separately. The outcomes of the results have been shown through flowing figures.
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Figure 24: Daily COVID-19 actual Deaths and predicted Deaths for the thirteen months and the
next seven days’ forecasted deaths by ARIMA model (p = 0, d = 1, q = (1, 6, 7)) based on Male.
Figure 24 shows the daily COVID-19 deaths for thirteen months, where actual death and
predicted deaths are compared, and also forecasted deaths for seven days after thirteen months
have been shown for male COVID-19 patients.
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Figure 25: Daily COVID-19 actual Deaths and predicted Deaths for the thirteen months and the
next seven days’ forecasted deaths by ARIMA model (p+d = 1, q = (1, 6, 7 )) based on the
female.
Here, the daily COVID-19 actual and predicted deaths of females for thirteen months have
been compared and seven day’s forecasted deaths based on the developed model are shown.
Then the evaluation metrics for this ARIMA model have been performed, which indicates
that MAE and RMSE of the developed model-based separately on females and males are lower
than that of the ARIMA model developed for the aggregate data on gender.
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Table 19: Evaluation Metrics for the developed ARIMA Model for COVID-19 Deaths based on
Gender
Evaluation Metrics for the ARIMA model (p = 0, d = 1, and q = (1, 6, 7)) of
Thirteen Months COVID-19 Deaths
Values not Based on

Male

Female

17.84

10.38

9.29

25.56

14.59

13.34

Gender
Mean Absolute Error
(MAE)
Root Mean Squared
Error (RMSE)

5.6 Forecasting for COVID-19 log_Cases
In above, the study results of the COVID-19 log_Deaths variable have been discussed to
evaluate the performance of proc arima’s IDENTIFY statements. Now the same analysis is done
by using COVID-19 log_Cases in Florida. The findings results are discussed below.
In figure 26 daily COVID-19 log_Cases in Florida is shown, where the highest peak was
in January 2021. As there are identification stage, estimation, and diagnostic checking stage, and
forecasting stage in the ARIMA model, the gotten results of those three stages are discussed below
based on COVID-19 log_Cases.
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Figure 26: COVID-19 log_Cases is shown as a function of the Date
5.6.1 Model Identification for log_Cases variables
For getting stationary data the period of differencing 1 has been used in this IDENTIFY
stage, where the mean of COVID_19 log_Cases is 0.016 that is close to zero, the standard deviation
is 0.36 (table 20).
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Table 20: Descriptive Statistics for log_Cases series.
Name of Variable = log_Cases
Period(s) of Differencing

1

Mean of Working Series

0.016087

Standard Deviation

0.36009

Number of Observations

414

Observation(s) eliminated by differencing

1

In table 21, it can be seen that the log_Cases series data is without white noise as the pvalue for the first six lags are less than the alpha value,0.05. therefore, a model with log_Cases
series is built.

Table 21: Autocorrelation Analysis of log_Cases series.
Autocorrelation Check for White Noise
To Lag Chi-Square DF Pr > ChiSq Autocorrelations
6

71.35

6

<.0001

-0.392 0.048

-0.094 0.034

12

111.46

12

<.0001

0.264

-0.063 -0.074 -0.081 0.069

18

177.63

18

<.0001

-0.105 0.339

24

220.65

24

<.0001

0.031

0.064

-0.087 0.032

-0.047 0.275

-0.072 0.002

-0.082 -0.110

-0.074 0.020

-0.115

To make sure whether the log_cases series have stationarity, ACF plot that shows that ACF
decay slowly and autocorrelation in this plot changes, and the Augmented Dickey-Fuller (ADF)
tests, where p-values of the tau test for all zero mean, single mean, and trend are less than alpha
0.05, are considered. Therefore, based on both it is known that data is stationary
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Figure 27: Autocorrelation Analysis Plots for stationary series of the log_Cases.
Table 22: Augmented Dickey-Fuller (ADF) Tests for log_Cases variable
Augmented Dickey-Fuller Unit Root Tests
Type

Lags

Rho

Pr < Rho

Tau

Pr < Tau

Zero Mean

0

-573.797

0.0001

-31.14

<.0001

1

-761.906

0.0001

-20.04

<.0001

0

-574.788

0.0001

-31.18

1

-769.000

0.0001

0

-577.003

1

-784.541

Single Mean

Trend

F

Pr > F

<.0001

486.07

0.0010

-20.09

<.0001

201.92

0.0010

0.0001

-31.31

<.0001

490.24

0.0010

0.0001

-20.24

<.0001

204.83

0.0010
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Then the Extended Sample Autocorrelation Function (ESACF) table has been used to get
SAS suggestions for p, d, and q values. Then forecasting the next seven day’s value of log_Cases
for six months (March 12, 2020, to September 10, 2021), and nine months (March 12, 2020, to
December 06, 2021) models and comparing those forecasted value with the actual value the
performance of those recommended parameters have been justified. Besides that, the next seven
day’s value of log_Cases has been found for thirteen months(March 12, 2020, to April 30, 2021)
model.
Table 23: SAS recommended ESACF (Extended Sample Autocorrelation Function) Tables for
parameters p, d, and q

Table 23 shows SAS recommended parameters to fit one or more ARIMA models for the
first six months’ data, nine months’ data, and thirteen months' data in Florida.
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5.6.2 Estimation and diagnostic checking for log_Cases variable

In the estimate stage, SAS recommended parameters have been used to build models and
among those, the best performer models have been chosen based on the AIC value, and the SBC
value of those models. As shown in the previous discussion for obtaining the final model, the
ARIMA models with parameters that have the lowest AIC and SBC values have been chosen to
build the model, in this section similar work is also done for the ARIMA model of COVID-19
cases.
However, after building models with those parameters, it has been figured out that the
MA1,1; MA1,4; and MA1,6 are significant parameters at alpha 0.05 for six months, nine months,
and thirteen months data based on Maximum Likelihood Estimation tables. Therefore, p = 0, d =
1, and q = (1, 4, 6) parameters are taken to fit the ARIMA models for all three periods of months.
The fitted equation for all three periods of months are given below:
Fitted equation of ARIMA model (p = 0, d = 1, and q = (1, 4, 6 ) for Six months data:
𝑧𝑡 = 𝑒𝑡 − 0.52866𝑒𝑡−1 + 0.17001𝑒𝑡−4 + 0.20508𝑒𝑡−6

(7)

Fitted equation of ARIMA model (p = 0, d = 1, and q = (1, 4, 6 ) for Nine months data:
𝑧𝑡 = 𝑒𝑡 − 0.61926𝑒𝑡−1 + 0.13499 𝑒𝑡−4 + 0.20144𝑒𝑡−6

(8)

Fitted equation of ARIMA model (p = 0, d = 1, and q = (1, 4, 6 ) for Thirteen months data:
𝑧𝑡 = 𝑒𝑡 − 0.6524 𝑒𝑡−1 + 0.0479𝑒𝑡−4 + 0.24508𝑒𝑡−6
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(9)

Then the autocorrelation of residuals has been checked to be sure about the model’s
adequacy for this log_Cases series. As the p-values of the first six lags are higher than the alpha
value 0.05, the null hypothesis-no-autocorrelation hypothesis is not rejected for the developed
ARIMA model of all three periods of months (first six months, nine months, and thirteen months).
So the ARIMA models with parameters (p = 0, d = 1, q = (1, 4, 6 )) are adequate to do this analysis
for all three periods of data. Normality plots show that the normality of residuals has also been
maintained by this ARIMA model (p +d = 1, q = (1, 4, 6)) for all three periods of months.

5.6.3 Forecasting for Six months
By using FORECAST statements in the ARIMA model (p = 0, d = 1, q = (1, 4, 6 )) next
seven day’s forecasted values have been found for six months, nine months, and thirteen months.
The gotten results have been discussed below:
Table 24: Forecast for the ARIMA(p=0, d=1, q=(1, 4, 6 )) model for log_Cases variable of the first
six month’s data.
Forecasts for variable log_Cases for First Six Months
Obs
184

Forecast
Std Error
7.8119
0.3199

95% Confidence Limits
7.1849
8.4388

185

7.6869

0.3536

6.9939

8.3800

186

7.6537

0.3844

6.9003

8.4072

187

7.7675

0.4129

6.9582

8.5768

188

7.8013

0.4611

6.8976

8.7050

189

7.9179

0.5047

6.9288

8.9070

190

7.9179

0.5727

6.7954

9.0404
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Table 24 represents the forecasted values of the log_Cases for the next seven days, where the
log_Cases would be increased.

Figure 28: Forecast of log_ Cases for the ARIMA model (p = 0, d = 1, q = (1, 4, 6 )) for next 7
days first six month’s data with 95% confidence limits.
To evaluated the ARIMA model’s predicted performance, the actual values of log_Cases
have been compared to predicted values of log_Cases that are shown in figure 29.
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Figure 29: First six months’ daily COVID-19 actual log_cases, and predicted and forecasted
log_cases for the next seven days in Florida.
Figure 30 shows Comparing daily COVID-19 actual deaths and predicted deaths for the
first six months and forecasted Cases for the next seven days, where without log-transformed data
has been used. When the actual cases have been compared with the developed model’s forecasted
cases, it has been seen that the actual cases were increasing from September 11 to September 17,
2021. Therefore, the developed ARIMA model ( p = 0, d = 1, q = (1, 4, 6 ) performing well to
forecast the number of cases.
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Figure 30: Comparing daily COVID-19 actual deaths and predicted deaths for the first six
months and forecasted Cases for the next seven days.

5.6.4 Forecasting for Nine months
For nine months data same analysis like as previous has been done. From table 25 it is
obvious that log_Cases for the next seven days would be decreased.
Figure 31 shows forecasting of COVID-19 for log_Cases, where the number of log_Cases
would be decreasing from December 7 to December 13, 2020.
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Table 25: Forecast for the ARIMA (p = 0, d = 1, q = (1, 4, 6 )) model for log_Cases variable of
the first nine month’s data.
Forecasts for variable log_Cases for Nine Months
Obs

Forecast Std Error

95% Confidence Limits

271

9.2097

0.3189

8.5846

9.8347

272

9.2716

0.3412

8.6028

9.9404

273

9.2745

0.3622

8.5646

9.9844

274

9.2437

0.3820

8.4949

9.9924

275

9.2029

0.4159

8.3877

10.0181

276

9.1408

0.4473

8.2642

10.0174

277

9.1408

0.5023

8.1562

10.1253

Figure 31: Forecast of log_Cases for the ARIMA model (p = 0, d = 1, and q = (1, 4, 6 )) for the
next 7 days of the first nine months’ data with 95% confidence limits.
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Figure 32: Daily COVID-19 actual log_Cases and predicted log_Cases for the first Nine
months and forecasted log_Cases for the next seven days
In figure 32, the log of daily COVID-19 actual Cases and the predicted cases are shown
for the first 9 months, where it is obvious that the actual and predicted COVID-19 cases are fairly
comparable with each other. In the last part of the graph, which is indicated with the red dash, is
shown the forecasting value for 7 days based on the prediction made in the last nine months of
previous COVID-19 cases.
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Figure 33: Comparing the daily actual COVID-19 Cases with forecasted COVID-19 Cases for
the first nine months with seven days forecasting value.
In figure 33, the daily actual COVID-19 cases are compared with the forecasted COVID19 cases for seven days, where this forecasting has been done based on the prediction on the last
nine months of COVID-19 cases. This prediction is made from the actual COVID-19 cases of the
last nine months. In this figure, it is found that seven days actual COVID-19 cases are supporting
the forecasting result for seven days.
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5.6.5 Forecasting for Thirteen months
Developed ARIMA model for thirteen months has been given seven days forecasted values
than are shown in table 25, from where it can be seen that number of the log_cases would be
increasing for next seven day.
Table 26: Forecast for the ARIMA (p = 0, d = 1, q = (1, 4, 6 )) model for log_Cases variable of
the first nine month’s data.
Forecasts for variable log_Cases for Thirteen Months
Obs

Forecast

Std Error

416

8.4613

0.3024

7.8686

9.0540

417

8.5039

0.3201

7.8764

9.1314

418

8.5124

0.3370

7.8519

9.1728

419

8.5619

0.3530

7.8701

9.2537

420

8.5653

0.3727

7.8349

9.2957

421

8.5829

0.3914

7.8158

9.3500

422

8.5829

0.4367

7.7270

9.4388
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95% Confidence Limits

Figure 34: Forecast of log_Cases for the ARIMA model (p = 0, d = 1, q = (1, 6, 7)) for the next
7 days of the first nine months’ data with 95% confidence limits.
To represent the increase of COVID-19 log_Cases, figure 36 has been drowned below,
which also shows that the number of log_Cases would be increasing from May 1 to May 07, 2021.
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Figure 35: Daily COVID-19 actual log_Cases and predicted log_Cases for the thirteen months
and forecasted log_Cases for the next seven days
Figure 35 shows that the daily actual log_Cases and daily predicted log_Cases are showing
similar patterns over thirteen months. Therefore, it can be assumed that the performance of this
model is good. To justify the model performance figure 37 has been shown below, where data
without logarithmic form has been considered.
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Figure 36: Daily COVID-19 actual Cases and predicted Cases for the thirteen months and
forecasted Cases for the next seven days
Figure 36 shows that COVID-19 actual Cases and predicted cases for thirteen months are
showing approximately similar ups and downs.
After observing the previous analysis for COVID-19 Cases, it seems that the developed
ARIMA model (p = 0, d = 1, q = (1, 4, 6 )) is performing well. However, to compare these threeperiod models with other published works, MAE (Mean Absolute Error) and RMSE (Root Mean
Squared Error) have been used. In table 26, MAE values and RMSE values are given for six
months, nine months, and thirteen months’ duration. One journal [4] reported that MAE for
COVID-19 cases is 2967 in the ARIMA model (p+d = 23, q = 22) for January 20, 2020, to May
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21, 2020. Another journal [5] claimed that MSE for ARIMA model (p+d = 1, q = 0) is
7240024855.066816 for March to June 26, 2020.
Here, it is found that MAE and RMSE for other ARIMA models are higher than that of the
ARIMA model (p+d = 1, q =(1, 4, 6)), which has been developed in this study. Therefore, the
developed models for three periods of months that are forecasted the number of COVID-19 cases
for a short-term duration, which is 7 days in this study, fairly to conduct this type of analysis in
future with more datasets.
Table 27: Evaluation Metrics for the developed ARIMA Model for COVID-19 Cases
Evaluation Metrics for the ARIMA Model (p = 0, d = 1, q = (1, 4, 6 ))
for COVID-19 Cases
Six Months

Nine Months

Thirteen Months

Mean Absolute Error (MAE)

740.02

1035.75

1074.88

Root Mean Squared Error

1232.17

2006.87

1680.19

(RMSE)

Satrio et at [4] shows in their study that MAE is 2967 for ARIMA model (p+d = 23, q = 22)
of COVID-19 cases.
One online journal [5] shows that the MSE for ARIMA model (p+d = 1, q = 0) is
7240024855.067
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The findings of exploratory data analysis that suggests higher COVID-19 cases for females
compared to males across all time points considered in this thesis are taken into consideration by
evaluating the performance of final models by gender. It was noted in the exploratory data analysis
section that the total number of COVID-19 cases and the daily number of COVID-19 cases are
higher for females than that of males in Florida. Therefore, females are more affected by COVID19 compare to males in Florida. To explore further how gender relates to cases in Florida
developed ARIMA model (p = 0, d = 1, q = (1, 4, 6 )) of thirteen months has been run for male
and female separately, where the AIC and SBC values for the models based on females, and based
on males are lower than the model that is not based on gender.

Figure 37: Daily COVID-19 actual Cases and predicted Cases for the thirteen months and
forecasted Cases for the next seven days by ARIMA model (p = 0, d = 1, q = (1, 4, 6 )) based on
Male.
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To show the seven days’ forecasting performance of the ARIMA model (p = 0, d = 1, q =
(1, 4, 6 )) based on gender the following figures 37 and 38 have been drawn.
It is obvious from figure 38 that daily COVID -19 Cases and predicted Cases for males are
showing approximately similar ups and downs. And the forecasted seven days’ value shows that
the number of Cases for males would be increased for those days.

Figure 38: Daily COVID-19 actual Cases and predicted Cases for the thirteen months and
forecasted Cases for the next seven days by ARIMA model (p = 0, d = 1, q = (1, 4, 6 )) based on
females.
Figure 38 represents that actual and predicted Cases for females are close enough that it
can be said that the developed model is showing quite satisfying performance.
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Now the evaluation metrics for the ARIMA model(p = 0, d = 1, q = (1, 4, 6 ) with
considering gender also have been done to see the MAE and RMSE values. From table 27 it can
be seen that the MAE and RMSE of the developed model that is based on gender are lower than
that of the ARIMA model which is not based on gender.
Table 28: Evaluation Metrics for the developed ARIMA Model for COVID-19 Cases based on
Gender
Evaluation Metrics for the ARIMA model (p = 0, d = 1, and q = (1, 4, 6 )) of
Thirteen Months COVID-19 Cases
Values not Based on
Male
Gender
Mean Absolute Error
1074.88
500.32
(MAE)
Root Mean Squared
1680.19
775.019
Error (RMSE)

Female
563
881.95

Therefore, the gender-specific models appear to be better under both model comparison
criteria MAE and RMSE compared to models based on gender aggregated data.
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CHAPTER 6: CONCLUSION
COVID-19 pandemic has caused massive disruption to our current world. The impact and
enormous scale of this crisis causing a lot of fear, uncertainty, and anxiety across the whole world.
Therefore, it is crucial to understand the COVID-19 pandemic and its impacts on our society to
avoid future losses. In the study, an Evaluation of the Performance of Proc Arima’s Identify
Statement: A Data-driven Approach using Covid-19 Cases and Deaths in Florida, it can be seen
that the developed statistical ARIMA models have been performing well to better understand the
COVID-19 pandemic in one of the major states, Florida, in the United States.
For this study, data has been transformed into logarithmic and differencing forms so that
the stationarity of data can be achieved. To build ARIMA models for COVID-19 Deaths and Cases
ESACF (Extended Sample Autocorrelation Function) tables have been used where different SAS
suggestions for model parameters p (the order of the Autoregressive model), d (the order of the
differencing), and q (the order of the Moving Average model) have been considered for the given
values of p, d, and q. We have used p = 4, d = 1, and q = 8 as starting values for model identification.
To do this analysis ARIMA models have been developed, such as the ARIMA model (p =
0, d = 1, q = (1, 4, 6 )) for COVID-19 log_Cases, and ARIMA model (p = 0, d = 1, q = (1, 6, 7))
for COVID-19 log_Deaths, based on the suggestion that proc arima’s IDENTIFY statement
provided for COVID-19 log_Deaths and log_Cases data of six months, nine months and thirteen
months.
Then short-term (seven days) COVID-19 deaths and cases have been forecasted by those
models and compared the forecasted values with the actual values of the COVID-19 deaths and
cases to evaluate these ARIMA models’ performance. MAE and RMSE have been also considered
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to justify the models. Besides these deaths and case variables, gender variables also consider
building model that helps to get more accurate models with low MAE and RMSE values.
This selecting and building process of the ARIMA model with the COVID-19 dataset help
to test and compare the accuracy and make an optimal selection among other models that are used
in different research works for the COVID-19 dataset. Even though the previous publications have
mainly focused to forecast the COVID-19 cases and deaths for a long period, the accuracy rates of
those models are not satisfactory because of using a small size of data. Besides that, as it is an
ongoing pandemic, many variables can come to change the number of COVID-19 deaths and
cases. Therefore, forecasting the long time COVID-19 deaths and cases just based on COVID-19
Deaths and Cases variables are not enough. However, in this study large size of data is used to
develop models to forecast the seven-day’s COVID-19 Deaths and Cases with negligible errors.
The gotten results show that the ARIMA model has achieved good performance in the
COVID-19 deaths and cases for Florida. Therefore, this type of model could be helpful in the
instance where time and needed supplies are limited regarding the progress of the epidemic in any
county or worldwide for short-term forecasting. On the other hand, this short-term forecasting can
be useful for travel agencies, small businesses, education sectors, and hospitals, etc. to make shortterm planning.
However, this model can be more robust and useful for COVID-19 data analysis when age
group and gender are taken into consideration in the development of the prediction model. Besides
there is a possibility for the spread of this virus during holidays (including weekends), parties, and
other social events. We have chosen q = 8 so that the weekends were not missed from any of the
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suggested models. Other starting values of the parameters p, d, and q may be considered for future
research on the analysis of COVID-19 data and modeling approaches.
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